The library was further tested in four bioassays: proteasome inhibition, triple-negative breast cancer cell-based assay targeted for glutaminase inhibition, and Gram-positive and Gram-negative bacterial growth inhibition. This evidence concerns the gene GLS and triple-negative breast carcinoma.